Anebulo Pharmaceuticals Stock (NASDAQ:ANEB)
Previous Close
$1.97
52W Range
$1.62 - $3.71
50D Avg
$2.11
200D Avg
$2.41
Market Cap
$53.94M
Avg Vol (3M)
$6.03K
Beta
-1.02
Div Yield
-
ANEB Company Profile
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.